Evidence map›Paper›PMID 37117750›Full record

ArticleNature aging2022

Multidimensional single-cell analysis of human peripheral blood reveals characteristic features of the immune system landscape in aging and frailty.

Oscar Junhong Luo, Wen Lei, Guodong Zhu, Zhiyao Ren, Yudai Xu, Chanchan Xiao, Hongyi Zhang, Junxiang Cai, Zhiping Luo, Lijuan Gao and 16 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature aging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 1 pooled it
15.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 1 synthesis or guideline pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Targeting senescent EGR1Cell reports. Medicine · 2026
    Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 9 institutions in 5 countries.

Oscar Junhong Luo *Department of Systems Biomedical Sciences, School of Medicine, Jinan University, Guangzhou, China. luojh@jnu.edu.cn.ORCID 0000-0002-1266-3069
Wen Lei *Guangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Guangzhou, China.
Guodong Zhu *Guangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Guangzhou, China.
Zhiyao Ren *Department of Systems Biomedical Sciences, School of Medicine, Jinan University, Guangzhou, China.
Yudai XuGuangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Guangzhou, China.
Chanchan XiaoGuangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Guangzhou, China.
Hongyi ZhangGuangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Guangzhou, China.
Junxiang CaiDepartment of Geriatrics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Zhiping LuoDepartment of Geriatrics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Lijuan GaoGuangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Guangzhou, China.
Jun SuFirst Affiliated Hospital, Jinan University, Guangzhou, China.
Lei TangJiangsu Key Laboratory of Druggability of Biopharmaceuticals and State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
Wei GuoJiangsu Key Laboratory of Druggability of Biopharmaceuticals and State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
Huanxing SuDepartment of Microbiology and Immunology, School of Medicine; Institute of Geriatric Immunology, School of Medicine, Jinan University, Guangzhou, China.
Zhang-Jin ZhangDepartment of Microbiology and Immunology, School of Medicine; Institute of Geriatric Immunology, School of Medicine, Jinan University, Guangzhou, China.
Evandro Fei FangDepartment of Microbiology and Immunology, School of Medicine; Institute of Geriatric Immunology, School of Medicine, Jinan University, Guangzhou, China.ORCID 0000-0003-0355-7202
Yijun RuanThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Sean Xiao LengJohns Hopkins Center on Aging and Immune Remodeling, Division of Geriatric Medicine and Gerontology, Departments of Medicine, Molecular Microbiology and Immunology, Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0002-2690-8055
Zhenyu JuKey Laboratory of Regenerative Medicine of Ministry of Education, Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Institute of Aging and Regenerative Medicine, Jinan University, Guangzhou, China.
Huiling LouDepartment of Geriatrics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Junling GaoSchool of Public Health, Fudan University, Shanghai, China.
Nan PengDepartment of Rehabilitation, The Second Medical Center of Chinese PLA General Hospital, Beijing, China.
Jie ChenDepartment of Gastroenterology, Huadong Hospital; Department of Geriatrics, Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital, Fudan University, Shanghai, China.
Zhijun BaoDepartment of Gastroenterology, Huadong Hospital; Department of Geriatrics, Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital, Fudan University, Shanghai, China.
Feng LiuGuangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Guangzhou, China. pfys1103@126.com.
Guobing ChenGuangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Guangzhou, China. guobingchen@jnu.edu.cn.ORCID 0000-0002-2401-6168
Jinan University · CNFudan University · CNGuangzhou First People's Hospital · CNChina Pharmaceutical University · CNChinese PLA General Hospital · CNFirst Affiliated Hospital of Jinan University · CNGuangdong-Hongkong-Macau Joint Laboratory of Collaborative Innovation for Environmental Quality · CNJackson Laboratory · USJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Frailty is an intermediate status of the human aging process, associated with decompensated homeostasis and death. The immune phenotype of frailty and its underlying cellular and molecular processes remain poorly understood. We profiled 114,467 immune cells from cord blood, young adults and healthy and frail old adults using single-cell RNA and TCR sequencing. Here we show an age-dependent accumulation of transcriptome heterogeneity and variability in immune cells. Characteristic transcription factors were identified in given cell types of specific age groups. Trajectory analysis revealed cells from non-frail and frail old adults often fall into distinct paths. Numerous TCR clonotypes were shared among T-cell subtypes in old adults, indicating differential pluripotency and resilience capabilities of aged T cells. A frailty-specific monocyte subset was identified with exclusively high expression of long noncoding RNAs NEAT1 and MALAT1. Our study discovers human frailty-specific immune cell characteristics based on the comprehensive dimensions in the immune landscape of aging and frailty.

Indexed as

FrailtyAgedAgingFrail ElderlyHumansImmune SystemReceptors, Antigen, T-CellYoung AdultReceptors, Antigen, T-Cell

Identifiers

PMID37117750
OpenAlexW4224038110

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.